These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 78252)

  • 21. Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
    Lewin E
    Dan Med Bull; 2004 May; 51(2):184-206. PubMed ID: 16009056
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcimetic AMG 073 at 50 and 100 mg per day.
    Mansour J; Benyahia M; Harbouche L; Presne C; Moriniere P; Fournier A
    Kidney Int; 2003 Dec; 64(6):2324-5. PubMed ID: 14633162
    [No Abstract]   [Full Text] [Related]  

  • 23. Changing surgical indications in azotemic secondary hyperparathyroidism.
    Bradley EL; Wells JO
    Am Surg; 1975 Jun; 41(6):358-63. PubMed ID: 1092240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of parathyroid tumourigenesis in uraemia.
    Tominaga Y
    Nephrol Dial Transplant; 1999; 14 Suppl 1():63-5. PubMed ID: 10048455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of secondary hyperparathyroidism in uremia.
    Drüeke TB
    Am J Med Sci; 1999 Jun; 317(6):383-9. PubMed ID: 10372838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal responsiveness of serum parathyroid hormone to beta-adrenergic blockade in patients with secondary hyperparathyroidism.
    Kukreja SC; Williams GA; Vora NM; Hargis GK
    Horm Metab Res; 1981 Apr; 13(4):233-5. PubMed ID: 6113198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies.
    Muirhead N; Catto GR; Edward N; Adami S; Manning RM; O'Riordan JL
    Br Med J (Clin Res Ed); 1984 Jan; 288(6412):177-9. PubMed ID: 6419845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
    Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA
    Nephron; 1981; 27(3):127-33. PubMed ID: 7219643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the beta adrenergic system in uremia. Relationship with secondary hyperparathyroidism].
    Drüeke T; Lhoste F; Ulmann A; Larno S; Man NK; Zingraff J; Jungers P; Boissier JR; Crosnier J
    J Urol Nephrol (Paris); 1976; 82(4-5):347-51. PubMed ID: 940180
    [No Abstract]   [Full Text] [Related]  

  • 30. [Autologous epithelial body transplantation in the surgical treatment of secondary azotemic hyperparathyroidism].
    Frei U; Klempa I; Fassbinder W; Koch KM
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1315-9. PubMed ID: 611843
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic procedures in primary and secondary hyperparathyroidism or in hypercalcemia].
    Hey D; Schultis K
    Med Welt; 1969 Nov; 48():2655-7. PubMed ID: 5386517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 34. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
    Sugimoto R; Watanabe H; Ikegami K; Enoki Y; Imafuku T; Sakaguchi Y; Murata M; Nishida K; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    Kidney Int; 2017 Mar; 91(3):658-670. PubMed ID: 27988213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How complete is a total parathyroidectomy in uraemia?
    Farrington K; Varghese Z; Chan MK; Fernando ON; Baillod RA; Sweny P; Moorhead JF
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):743. PubMed ID: 3105723
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient.
    Sprague SM; Ho LT
    Clin Nephrol; 2002 Aug; 58(2):155-60. PubMed ID: 12227689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.
    Shiizaki K; Negi S; Mizobuchi M; Hatamura I; Narukawa N; Sakaguchi T; Kitabata Y; Sumikado S; Akizawa T
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii42-6. PubMed ID: 12771299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cimetidine in secondary hyperparathyroidism.
    Kovarik J; Graf H; Woloszczuk W; Stummvoll HK
    Ann Intern Med; 1982 Mar; 96(3):379. PubMed ID: 7059107
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
    Pizzarelli F; Zoccali C; Ciccarelli C; Maggiore Q; Bonucci E; Ballanti P
    Nephron; 1982; 32(1):93-4. PubMed ID: 7177287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural course of secondary hyperparathyroidism after successful renal transplantation.
    Roof BS; Piel CF; Carpenter BJ; Gordan GS; Kountz S; Belzer F
    Proc Clin Dial Transplant Forum; 1971; 1():11-20. PubMed ID: 4951041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.